Wells Fargo’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Buy |
|
|||||
|
2025
Q1 | $171K | Buy |
|
|||||
|
2024
Q4 | $241K | Buy |
|
|||||
|
2024
Q3 | $642K | Sell |
|
|||||
|
2024
Q2 | $526K | Buy |
|
|||||
|
2024
Q1 | $616K | Buy |
|
|||||
|
2023
Q4 | $236K | Sell |
|
|||||
|
2023
Q3 | $486K | Sell |
|
|||||
|
2023
Q2 | $857K | Buy |
|
|||||
|
2023
Q1 | $611K | Buy |
|
|||||
|
2022
Q4 | $2.26K | Sell |
|
|||||
|
2022
Q3 | $25K | Sell |
|
|||||
|
2022
Q2 | $115K | Buy |
|
|||||
|
2022
Q1 | $81K | Sell |
|
|||||
|
2021
Q4 | $400K | Buy |
|
|||||
|
2021
Q3 | $0 | Sell |
|
|||||
|
2021
Q2 | $0 | Sell |
|
|||||
|
2021
Q1 | $27K | Sell |
|
|||||
|
2020
Q4 | $1.38M | Buy |
|
|||||
|
2020
Q3 | $483K | Buy |
|
|||||
|
2020
Q2 | $451K | Buy |
|